Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells. / Wang, Chris Kedong; Nelepcu, Irina; Hui, Desmond; Oo, Htoo Zarni; Truong, Sarah; Zhao, Sarah; Tahiry, Zakir; Esfandnia, Shaghayegh; Ghaidi, Fariba; Adomat, Hans; Dagil, Robert; Gustavsson, Tobias; Choudhary, Swati; Salanti, Ali; Sorensen, Poul H; Al Nakouzi, Nader; Daugaard, Mads.

In: Scientific Reports, Vol. 12, 3075, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Wang, CK, Nelepcu, I, Hui, D, Oo, HZ, Truong, S, Zhao, S, Tahiry, Z, Esfandnia, S, Ghaidi, F, Adomat, H, Dagil, R, Gustavsson, T, Choudhary, S, Salanti, A, Sorensen, PH, Al Nakouzi, N & Daugaard, M 2022, 'Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells', Scientific Reports, vol. 12, 3075. https://doi.org/10.1038/s41598-022-07025-6

APA

Wang, C. K., Nelepcu, I., Hui, D., Oo, H. Z., Truong, S., Zhao, S., Tahiry, Z., Esfandnia, S., Ghaidi, F., Adomat, H., Dagil, R., Gustavsson, T., Choudhary, S., Salanti, A., Sorensen, P. H., Al Nakouzi, N., & Daugaard, M. (2022). Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells. Scientific Reports, 12, [3075]. https://doi.org/10.1038/s41598-022-07025-6

Vancouver

Wang CK, Nelepcu I, Hui D, Oo HZ, Truong S, Zhao S et al. Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells. Scientific Reports. 2022;12. 3075. https://doi.org/10.1038/s41598-022-07025-6

Author

Wang, Chris Kedong ; Nelepcu, Irina ; Hui, Desmond ; Oo, Htoo Zarni ; Truong, Sarah ; Zhao, Sarah ; Tahiry, Zakir ; Esfandnia, Shaghayegh ; Ghaidi, Fariba ; Adomat, Hans ; Dagil, Robert ; Gustavsson, Tobias ; Choudhary, Swati ; Salanti, Ali ; Sorensen, Poul H ; Al Nakouzi, Nader ; Daugaard, Mads. / Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells. In: Scientific Reports. 2022 ; Vol. 12.

Bibtex

@article{be8cb5c32c2648b6a8fa472c8facecbc,
title = "Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells",
abstract = "Proteoglycans are proteins that are modified with glycosaminoglycan chains. Chondroitin sulfate proteoglycans (CSPGs) are currently being exploited as targets for drug-delivery in various cancer indications, however basic knowledge on how CSPGs are internalized in tumor cells is lacking. In this study we took advantage of a recombinant CSPG-binding lectin VAR2CSA (rVAR2) to track internalization and cell fate of CSPGs in tumor cells. We found that rVAR2 is internalized into cancer cells via multiple internalization mechanisms after initial docking on cell surface CSPGs. Regardless of the internalization pathway used, CSPG-bound rVAR2 was trafficked to the early endosomes in an energy-dependent manner but not further transported to the lysosomal compartment. Instead, internalized CSPG-bound rVAR2 proteins were secreted with exosomes to the extracellular environment in a strictly chondroitin sulfate-dependent manner. In summary, our work describes the cell fate of rVAR2 proteins in tumor cells after initial binding to CSPGs, which can be further used to inform development of rVAR2-drug conjugates and other therapeutics targeting CSPGs.",
author = "Wang, {Chris Kedong} and Irina Nelepcu and Desmond Hui and Oo, {Htoo Zarni} and Sarah Truong and Sarah Zhao and Zakir Tahiry and Shaghayegh Esfandnia and Fariba Ghaidi and Hans Adomat and Robert Dagil and Tobias Gustavsson and Swati Choudhary and Ali Salanti and Sorensen, {Poul H} and {Al Nakouzi}, Nader and Mads Daugaard",
note = "{\textcopyright} 2022. The Author(s).",
year = "2022",
doi = "10.1038/s41598-022-07025-6",
language = "English",
volume = "12",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells

AU - Wang, Chris Kedong

AU - Nelepcu, Irina

AU - Hui, Desmond

AU - Oo, Htoo Zarni

AU - Truong, Sarah

AU - Zhao, Sarah

AU - Tahiry, Zakir

AU - Esfandnia, Shaghayegh

AU - Ghaidi, Fariba

AU - Adomat, Hans

AU - Dagil, Robert

AU - Gustavsson, Tobias

AU - Choudhary, Swati

AU - Salanti, Ali

AU - Sorensen, Poul H

AU - Al Nakouzi, Nader

AU - Daugaard, Mads

N1 - © 2022. The Author(s).

PY - 2022

Y1 - 2022

N2 - Proteoglycans are proteins that are modified with glycosaminoglycan chains. Chondroitin sulfate proteoglycans (CSPGs) are currently being exploited as targets for drug-delivery in various cancer indications, however basic knowledge on how CSPGs are internalized in tumor cells is lacking. In this study we took advantage of a recombinant CSPG-binding lectin VAR2CSA (rVAR2) to track internalization and cell fate of CSPGs in tumor cells. We found that rVAR2 is internalized into cancer cells via multiple internalization mechanisms after initial docking on cell surface CSPGs. Regardless of the internalization pathway used, CSPG-bound rVAR2 was trafficked to the early endosomes in an energy-dependent manner but not further transported to the lysosomal compartment. Instead, internalized CSPG-bound rVAR2 proteins were secreted with exosomes to the extracellular environment in a strictly chondroitin sulfate-dependent manner. In summary, our work describes the cell fate of rVAR2 proteins in tumor cells after initial binding to CSPGs, which can be further used to inform development of rVAR2-drug conjugates and other therapeutics targeting CSPGs.

AB - Proteoglycans are proteins that are modified with glycosaminoglycan chains. Chondroitin sulfate proteoglycans (CSPGs) are currently being exploited as targets for drug-delivery in various cancer indications, however basic knowledge on how CSPGs are internalized in tumor cells is lacking. In this study we took advantage of a recombinant CSPG-binding lectin VAR2CSA (rVAR2) to track internalization and cell fate of CSPGs in tumor cells. We found that rVAR2 is internalized into cancer cells via multiple internalization mechanisms after initial docking on cell surface CSPGs. Regardless of the internalization pathway used, CSPG-bound rVAR2 was trafficked to the early endosomes in an energy-dependent manner but not further transported to the lysosomal compartment. Instead, internalized CSPG-bound rVAR2 proteins were secreted with exosomes to the extracellular environment in a strictly chondroitin sulfate-dependent manner. In summary, our work describes the cell fate of rVAR2 proteins in tumor cells after initial binding to CSPGs, which can be further used to inform development of rVAR2-drug conjugates and other therapeutics targeting CSPGs.

U2 - 10.1038/s41598-022-07025-6

DO - 10.1038/s41598-022-07025-6

M3 - Journal article

C2 - 35197518

VL - 12

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 3075

ER -

ID: 298630292